Filing Flows › Cerenome (CNSY) › Q1 2026
Cerenome (CNSY) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 15, 2026
Cerenome (CNSY) reported revenue of $1.0M for the first quarter 2026 (Q1 2026), -3% from a year earlier and -25% from the quarter before. Operating margin was -692.5%, net loss $6.9M (675.7% of revenue).
Cerenome, Q1 2026: revenue $1.0M (-3% year over year), operating margin -692.5%, net loss $6.9M, operating cash flow −$6.2M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0M | -25% | -3% |
| Operating profit | −$7.1M | — | — |
| Net earnings | −$6.9M | — | — |
| Operating cash flow | −$6.2M | — | — |
What changed
Revenue was $1.0M in Q1 2026, down 3% year over year and down 25% from the previous quarter.
Operating costs exceeded revenue by $7.1M, an operating margin of -692.5%. Total costs grew 77% against a revenue fall of 3%. The fastest-growing cost line was General & admin (+86%). The quarter ended with a net loss of $6.9M, wider than the previous quarter's $5.7M loss.
Operating cash flow was −$6.2M. Non-cash charges added back $96K of depreciation and amortization and $1.0M of share-based compensation. Working capital and other items used $410K. Capital expenditures of $818K exceeded it, leaving free cash flow of −$7.1M.
Questions
What was Cerenome's revenue in the first quarter 2026?
Cerenome (CNSY) reported revenue of $1.0M for the first quarter 2026 (Q1 2026), -3% from a year earlier and -25% from the quarter before.
Was Cerenome profitable in the first quarter 2026?
Operating loss was $7.1M (-692.5% of revenue) and net loss $6.9M.
Source: Cerenome 10-Q on SEC EDGAR.